Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (6): 1157-1161. doi: 10.19723/j.issn.1671-167X.2020.06.030

Previous Articles     Next Articles

  

  • Received:2020-07-31 Online:2020-12-18 Published:2020-12-13
  • Supported by:
    Shenzhen Sanming Project of Shenzhen Municipal Health Commission(SZSM201612009);Natural Science Foundation of Guangdong Province(2019A1515011112);National Natural Science Foundation of China(81974253)

RICH HTML

   

PDF (PC)

CLC Number: 

  • R593.22

Figure 1

Changes of lymphedema before and after the treatment A, the lymphedema of the right upper limb on admission; B, the lymphedema of the right upper limb was reduced by about 50% after 2 weeks of treatment; C, the lymphedema of the right upper limb has completely subsided after 1 year of follow-up."

Table 1

Demographics of 50 patients recruited into the study"

Items Value
Male/Female* 20 (42%)/28 (58%)
Age of presentation/years* 56 (14-73)
Age of RA onset/years 45±13
Age of lymphedema onset/years 53.0±11.6
Duration before lymphedema/year* 5 (0-32)
≤1 year 10 (21%)
≥2 years 38 (79%)
Site of lymphedema
Upper limbs 37 (74%)
Bilateral 19 (38%)
Unilateral 18 (36%)
Lower limbs 12 (24%)
Bilateral 9 (18%)
Unilateral 3 (6%)
Upper and lower limbs 1 (2%)
Rheumatoid factor (n=48)*
Positive 31 (65%)
Negative 17 (35%)
Activity of RA#
Active 20 (50%)
Quiescent 20 (50%)
[1] Kalliomäki JL, Vastamäki M. Chronic diffuse oedema of the rheumatoid hand: a sign of local lymphatic involvement[J]. Ann Rheum Dis, 1968,27(2):167-169.
doi: 10.1136/ard.27.2.167 pmid: 5651232
[2] Hart FD. Rheumatoid arthritis: extra-articular manifestations[J]. Br Med J, 1970,2(5712):747-752.
doi: 10.1136/bmj.2.5712.747 pmid: 5428736
[3] de Silva RT, Grennan GM, Palmer DG. Lymphatic obstruction in rheumatoid arthritis: a cause for upper limb oedema[J]. Ann Rheum Dis, 1980,39(3):260-265.
doi: 10.1136/ard.39.3.260 pmid: 7416816
[4] Kyle VM, de Silva M, Hurst G. Rheumatoid lymphedema[J]. Clin Rheumatol, 1982,1(2):126-127.
doi: 10.1007/BF02275602 pmid: 6926809
[5] Grillet B, Dequeker J. Rheumatoid lymphedema[J]. J Rheumatol, 1987,14(6):1095-1097.
pmid: 3509983
[6] Wijnands MJ, Corstens FH, van der Heijde DM, et al. Lymphatic obstruction as a cause of oedema in rheumatoid arthritis[J]. Neth J Med, 1988,33(3/4):140-143.
[7] Dacre JE, Scott DL, Huskisson EC. Lymphedema of the limbs as an extra-articular feature of rheumatoid arthritis[J]. Ann Rheum Dis, 1990,49(9):722-724.
pmid: 2241291
[8] Bamji A. Limb lymphoedema in rheumatoid arthritis[J]. Ann Rheum Dis, 1991,50(6):407.
doi: 10.1136/ard.50.6.407 pmid: 2059087
[9] Lacroix HR, Gruwez JA, Daele CV, et al. Lymphedema of the leg associated with rheumatoid arthritis[J]. Lymphology, 1991,24(2):68-70.
pmid: 1921478
[10] Gschwind C, Pfeiffer KM. Rheumatoid lymphedema: a case report[J]. J Hand Surg Am, 1993,18(6):992-994.
pmid: 8294761
[11] Joos E, Bourgeois P, Famaey JP. Lymphatic disorders in rheumatoid arthritis[J]. Semin Arthritis Rheum, 1993,22(6):392-398.
doi: 10.1016/s0049-0172(05)80031-9 pmid: 8342046
[12] Minari C, Cecconami L, Fioravanti A, et al. Lymphoedema of the limbs in rheumatoid arthritis[J]. Clin Rheumatol, 1994,13(3):464-469.
pmid: 7835011
[13] Sant SM, Tormey VJ, Freyne P, et al. Lymphatic obstruction in rheumatoid arthritis[J]. Clin Rheumatol, 1995,14(4):445-450.
doi: 10.1007/BF02207680 pmid: 7586983
[14] Ostrov BE. Beneficial effect of etanercept on rheumatoid lymphe-dema[J]. Arthritis Rheum, 2001,44(1):240-241.
doi: 10.1002/1529-0131(200101)44:1<240::AID-ANR32>3.0.CO;2-# pmid: 11212167
[15] Kogure T, Hoshino A, Ito K, et al. Beneficial effect of complementary alternative medicine on lymphedema with rheumatoid arthritis[J]. Mod Rheumatol, 2005,15(6):445-449.
doi: 10.1007/s10165-005-0438-2
[16] Eyigor S, Karapolat H, Kirazli Y. Efficacy of etanercept and complete decongestive physical therapy in bilateral lower-limb lym-phoedema associated with rheumatoid arthritis: A case report[J]. Adv Ther, 2008,25(1):23-28.
doi: 10.1007/s12325-008-0006-1
[17] Tily HI, Perl A. Lymphoedema: a paradoxical effect of tumour necrosis factor inhibitors: case report and review of literature[J]. BMJ Case Rep, 2009, bcr07. 2008. 0520. doi: 10.1136/bcr.07.2008.0520.
[18] Kuroyanagi G, Yamada K, Imaizumi T, et al. Leg lymphedema caused by iliopectineal bursitis associated with destruction of a rheumatoid hip joint: A case report[J]. Exp Ther Med, 2013,6(4):887-890.
doi: 10.3892/etm.2013.1243
[19] Béji M, Bouomrani S, Bouassida N, et al. Unilateral upper limb lymphedema in elderly rheumatoid arthritis[J]. Eur Geriatr Med, 2013,4(Suppl 1):S135.
[20] Breznik V, Dai K, Marovt M. Chronic peripheral edema in a patient with rheumatoid arthritis[J]. Acta Dermatovenerol Alp Pannonica Adriat, 2018,27(1):37-39.
pmid: 29589645
[21] 左晓霞, 鲍春德, 陈顺乐. 类风湿关节炎伴肢体淋巴性水肿的诊治二例报告[J]. 湖南医学, 1995,12(4):228-229.
[22] 戴冽, 汤美安. 强直性脊柱炎并类风湿性关节炎伴肢体淋巴性水肿1例[J]. 中国实用内科杂志, 1999,19(4):251.
[23] Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system[J]. Clin Med, 2004,4(5):448-453.
doi: 10.7861/clinmedicine.4-5-448
[24] Grada AA, Phillips TJ. Lymphedema: Pathophysiology and clinical manifestations[J]. J Am Acad Dermatol, 2017,77(6):1009-1020.
pmid: 29132848
[25] Mcrorie ER, Reid DM, Dunn NA, et al. Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia[J]. Br J Rheumatol, 1995,34(7):689-691.
doi: 10.1093/rheumatology/34.7.689 pmid: 7670794
[26] Jayson MI, Barks JS. Oedema in rheumatoid arthritis: Changes in the coefficient of capillary filtration[J]. BMJ, 1971,2(5761):555-557.
pmid: 5579191
[27] Schmit P, Prieur AM, Brunelle F. Juvenile rheumatoid arthritis and lymphoedema: lymphangiographic aspects[J]. Pediatr Radiol, 1999,29(5):364-366.
doi: 10.1007/s002470050608 pmid: 10382216
[28] Bardare M, Falcini F, Cate HT, et al. Idiopathic limb edema in children with chronic arthritis: A multicenter report of 12 cases[J]. J Rheumatol, 1997,24(2):384-388.
pmid: 9035001
[29] Maclellan RA, Greene AK. Lymphedema[J]. Semin Pediatr Surg, 2014,23(4):191-197.
doi: 10.1053/j.sempedsurg.2014.07.004 pmid: 25241097
[30] Grada AA, Phillips TJ. Lymphedema: Diagnostic workup and management[J]. J Am Acad Dermatol, 2017,77(6):995-1006.
doi: 10.1016/j.jaad.2017.03.021 pmid: 29132859
[31] Liu N. MR lymphangiography [M]// Lee BB, Rockson S, Bergan J. Lymphedema. Berlin, Germany: Springer, Cham: 2018. https://doi.org/10.1007/978-3-319-52423-8_27.
[1] Hui WEI, Jingfeng ZHANG, Zhongqiang YAO, Jinxia ZHAO. Clinical characteristics and relevant factors of rheumatoid arthritis patients with anemia of chronic disease [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 307-312.
[2] Tao WU, Jianzi LIN, Yafeng ZHU, Jianda MA, Peiwen JIA, Lijuan YANG, jie PAN, Yaowei ZOU, Ying YANG, Ye LU, Lie DAI. Serum inter-alpha-trypsin inhibitor heavy chain H3 is identified as a potential biomarker for myopenia in patients with rheumatoid arthritis using proteomic profiling [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1024-1031.
[3] Yajing GAO, Zhengfang LI, Mengsi MA, Lijun WU. Role of the SII and SIRI in risk prediction, disease activity assessment, and prog-nostic evaluation of Behçet disease uveitis [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1067-1073.
[4] Xuebing LYU, Xuanhua YU, Weizhen ZHANG, Changquan LIU, Huhan LIN, Shanting ZENG, Huijuan HUANG, Yueping WU. Rheumatoid arthritis complicated with necrotizing fasciitis: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1198-1202.
[5] Ju YANG, Jing XU, Juhua DAI, Lianjie SHI. Expression of lumican protein in serum of patients with rheumatoid arthritis and its correlation with disease and immune activities [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 911-918.
[6] Lianghua FENG, Lirong HONG, Yujia CHEN, Xueming CAI. Role and mechanism of ubiquitin-specific protease 35 in ferroptosis of rheumatoid arthritis-fibroblast like synoviocytes [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 919-925.
[7] Yijun HAN, Xiaoli CHEN, Changhong LI, Jinxia ZHAO. Application status of methotrexate in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 994-1000.
[8] Peiwen JIA, Ying YANG, Yaowei ZOU, Zhiming OUYANG, Jianzi LIN, Jianda MA, Kuimin YANG, Lie DAI. Clinical characteristics of overlapping syndromes of low muscle mass in patients with rheumatoid arthritis and their impact on physical function [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1009-1016.
[9] Doudou MA, Zhemin LU, Qian GUO, Sha ZHU, Jin GU, Yan DING, Lianjie SHI. Successful treatment of rheumatoid arthritis complicated with myasthenia gravis with low-dose rituximab: A case report [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 1110-1114.
[10] Rui YAN, Dan KE, Yan ZHANG, Li LI, Huanran SU, Wei CHEN, Mingxia SUN, Xiaomin LIU, Liang LUO. Diagnostic significance of serum chemokine CXCL-10 and Krebs von den lungen-6 level in patients with rheumatoid arthritis associated interstitial lung disease [J]. Journal of Peking University (Health Sciences), 2024, 56(6): 956-962.
[11] Zhengfang LI,Cainan LUO,Lijun WU,Xue WU,Xinyan MENG,Xiaomei CHEN,Yamei SHI,Yan ZHONG. Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(4): 729-734.
[12] Huina HUANG,Jing ZHAO,Xiangge ZHAO,Ziran BAI,Xia LI,Guan WANG. Regulatory effect of lactate on peripheral blood CD4+ T cell subsets in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 519-525.
[13] Xiaofei TANG,Yonghong LI,Qiuling DING,Zhuo SUN,Yang ZHANG,Yumei WANG,Meiyi TIAN,Jian LIU. Incidence and risk factors of deep vein thrombosis in patients with rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 279-283.
[14] Xue ZOU,Xiao-juan BAI,Li-qing ZHANG. Effectiveness of tofacitinib combined with iguratimod in the treatment of difficult-to-treat moderate-to-severe rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 1013-1021.
[15] Yin-ji JIN,Lin SUN,Jin-xia ZHAO,Xiang-yuan LIU. Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 631-635.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd